Journey Medical Corporation to Participate in the Lake Street Capital Markets 8th Annual Best Ideas Growth (BIG) Conference
Journey Medical (Nasdaq: DERM), a commercial-stage pharmaceutical company specializing in FDA-approved dermatological treatments, has announced its participation in the Lake Street Capital Markets 8th Annual Best Ideas Growth (BIG) Conference. The event is set to take place on Thursday, September 12, 2024 in New York City.
Claude Maraoui, President and CEO of Journey Medical, will be attending the conference to engage in one-on-one meetings with investors and industry professionals. This participation underscores the company's commitment to growth and investor relations in the pharmaceutical sector, particularly in the field of dermatology.
Journey Medical (Nasdaq: DERM), un'azienda farmaceutica in fase commerciale specializzata in trattamenti dermatologici approvati dalla FDA, ha annunciato la sua partecipazione alla 8ª Conferenza Annuale delle Migliori Idee di Lake Street Capital Markets (BIG). L'evento si svolgerà giovedì 12 settembre 2024 a New York City.
Claude Maraoui, Presidente e CEO di Journey Medical, parteciperà alla conferenza per partecipare a incontri individuali con investitori e professionisti del settore. Questa partecipazione sottolinea l'impegno dell'azienda per la crescita e le relazioni con gli investitori nel settore farmaceutico, in particolare nel campo della dermatologia.
Journey Medical (Nasdaq: DERM), una empresa farmacéutica en etapa comercial especializada en tratamientos dermatológicos aprobados por la FDA, ha anunciado su participación en la 8ª Conferencia Anual de Mejores Ideas de Lake Street Capital Markets (BIG). El evento se llevará a cabo el jueves 12 de septiembre de 2024 en la ciudad de Nueva York.
Claude Maraoui, Presidente y CEO de Journey Medical, asistirá a la conferencia para participar en reuniones uno a uno con inversores y profesionales de la industria. Esta participación subraya el compromiso de la empresa con el crecimiento y las relaciones con los inversores en el sector farmacéutico, especialmente en el campo de la dermatología.
여행 의료(Journey Medical) (Nasdaq: DERM)는 FDA에서 승인한 피부과 치료제를 전문으로 하는 상업 단계 제약 회사로, 레이크 스트리트 캐피탈 마켓 8차 연례 최고의 아이디어 성장(BIG) 컨퍼런스에 참여한다고 발표했습니다. 이 행사는 2024년 9월 12일 목요일 뉴욕시에서 열릴 예정입니다.
여행 의료의 회장 겸 CEO인 클로드 마라우이는 투자자 및 업계 전문가와 일대일 회의에 참석하기 위해 컨퍼런스에 참석할 예정입니다. 이번 참여는 제약 분야, 특히 피부과에서 성장 및 투자자 관계에 대한 회사의 의지를 강조합니다.
Journey Medical (Nasdaq: DERM), une entreprise pharmaceutique en phase commerciale spécialisée dans les traitements dermatologiques approuvés par la FDA, a annoncé sa participation à la 8ème Conférence Annuelle des Meilleures Idées de Lake Street Capital Markets (BIG). L'événement se déroulera le jeudi 12 septembre 2024 à New York.
Claude Maraoui, Président et CEO de Journey Medical, assistera à la conférence pour participer à des réunions individuelles avec des investisseurs et des professionnels du secteur. Cette participation souligne l'engagement de l'entreprise envers la croissance et les relations avec les investisseurs dans le secteur pharmaceutique, en particulier dans le domaine de la dermatologie.
Journey Medical (Nasdaq: DERM), ein pharmazeutisches Unternehmen in der Handelsphase, das sich auf von der FDA zugelassene dermatologische Behandlungen spezialisiert hat, hat seine Teilnahme an der 8. jährlichen Best Ideas Growth (BIG) Konferenz von Lake Street Capital Markets angekündigt. Die Veranstaltung findet am Donnerstag, den 12. September 2024 in New York City statt.
Claude Maraoui, Präsident und CEO von Journey Medical, wird an der Konferenz teilnehmen, um Eins-zu-eins-Meetings mit Investoren und Branchenprofis zu führen. Diese Teilnahme unterstreicht das Engagement des Unternehmens für Wachstum und Investorenbeziehungen im Pharmasektor, insbesondere im Bereich Dermatologie.
- None.
- None.
SCOTTSDALE, Ariz., Sept. 09, 2024 (GLOBE NEWSWIRE) -- Journey Medical Corporation (“Journey Medical” or “the Company”) (Nasdaq: DERM), a commercial-stage pharmaceutical company that primarily focuses on the selling and marketing of U.S. Food and Drug Administration (“FDA”)-approved prescription pharmaceutical products for the treatment of dermatological conditions, today announced that Claude Maraoui, President and Chief Executive Officer, will attend one-on-one meetings at the Lake Street Capital Markets 8th Annual Best Ideas Growth (BIG) Conference, scheduled to take place on Thursday, September 12, 2024 in New York City.
About Journey Medical Corporation
Journey Medical Corporation (Nasdaq: DERM) (“Journey Medical”) is a commercial-stage pharmaceutical company that primarily focuses on the selling and marketing of FDA-approved prescription pharmaceutical products for the treatment of dermatological conditions through its efficient sales and marketing model. The Company currently markets seven branded and two generic products that help treat and heal common skin conditions. The Journey Medical team comprises industry experts with extensive experience in developing and commercializing some of dermatology’s most successful prescription brands. Journey Medical is located in Scottsdale, Arizona and was founded by Fortress Biotech, Inc. (Nasdaq: FBIO). Journey Medical’s common stock is registered under the Securities Exchange Act of 1934, as amended, and it files periodic reports with the U.S. Securities and Exchange Commission (“SEC”). For additional information about Journey Medical, visit www.journeymedicalcorp.com.
Company Contact:
Jaclyn Jaffe
(781) 652-4500
ir@jmcderm.com
Media Relations Contact:
Tony Plohoros
6 Degrees
(908) 591-2839
tplohoros@6degreespr.com
FAQ
When is Journey Medical (DERM) participating in the Lake Street Capital Markets Conference?
Who will represent Journey Medical (DERM) at the Lake Street Capital Markets Conference?
What type of meetings will Journey Medical (DERM) have at the Lake Street Capital Markets Conference?
Where is the Lake Street Capital Markets Conference taking place for Journey Medical (DERM)?
What is the main focus of Journey Medical (DERM)?
